Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research: Workshop Summary

by Steve Olson, Adam C. Berger

Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research.

67 pages, ebook

First published January 1, 2010

About the author

Steve Olson is the author of Eruption: The Untold Story of Mount St. Helens (winner of a Washington State Book Award), Mapping Human History (a finalist for the National Book Award), and other books. He lives in Seattle, Washington.